Scott Gottlieb
FDA’s Dr. Gottlieb Chastises Big Pharma for Biosimilar Entry Delays
Of the 11 biosimilars approved by the FDA, only three have reached the U.S. market.
JULY 23, 2018
Federal Working Group to Consider Importing Prescription Drugs
The working group will examine importation of drugs that have seen significant price increases or access challenges ...
JULY 22, 2018
Load more